Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8751)
All Articles published online
|
Publishing Process of This Article
|
Oct 7, 2019 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Magrì S, Paduano D, Chicco F, Cingolani A, Farris C, Delogu G, Tumbarello F, Lai M, Melis A, Casula L, Fantini MC, Usai P. Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history. World J Gastroenterol 2019; 25(37): 5676-5686 [PMID: 31602167 DOI: 10.3748/wjg.v25.i37.5676] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i37/5676.htm |
| Number | Citing Articles |
| 1 |
Hirsh D. Trivedi, Emily W. Lopes, Jeremy Glissen Brown, Shaan Dudani, Michelle Lai, Joseph D. Feuerstein, Theodore T. Pierce. Steroid Use and Risk of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease. Journal of Clinical Gastroenterology 2023; 57(6): 610 doi: 10.1097/MCG.0000000000001727
|
| 2 |
Scott McHenry, Matthew Glover, Ali Ahmed, Quazim Alayo, Maria Zulfiqar, Daniel R Ludwig, Matthew A Ciorba, Nicholas O Davidson, Parakkal Deepak. NAFLD Is Associated With Quiescent Rather Than Active Crohn’s Disease. Inflammatory Bowel Diseases 2023; doi: 10.1093/ibd/izad129
|
| 3 |
Samuel J. Martínez-Domínguez, Sandra García-Mateo, Viviana Laredo, Carla J. Gargallo-Puyuelo, Beatriz Gallego Llera, Julia López de la Cruz, Fernando Gomollón. Liver Fibrosis in Non-Alcoholic Fatty Liver Disease and Progression to Hepatocellular Carcinoma in Patients with Inflammatory Bowel Disease: A Systematic Review. Cancers 2023; 15(13): 3367 doi: 10.3390/cancers15133367
|
| 4 |
Shaya Noorian, Yejoo Jeon, Minh T Nguyen, Jenny Sauk, Berkeley N Limketkai. The Impact of NAFLD on Hospitalization Outcomes in Patients With Inflammatory Bowel Diseases: Nationwide Analysis. Inflammatory Bowel Diseases 2022; 28(6): 878 doi: 10.1093/ibd/izab199
|
| 5 |
Juan Carlos Rodriguez-Duque, José Luis Calleja, Paula Iruzubieta, Marta Hernández-Conde, Coral Rivas-Rivas, María Isabel Vera, Maria Jose Garcia, Marta Pascual, Beatriz Castro, Agustín García-Blanco, Enrique García-Nieto, Soraya Curiel-del Olmo, María Luisa Cagigal, Lorena Lopez-Montejo, Tatiana Fernández-Lamas, Laura Rasines, José Ignacio Fortea, José Pedro Vaque, Yza Frias, Montserrat Rivero, María Teresa Arias-Loste, Javier Crespo. Increased risk of MAFLD and Liver Fibrosis in Inflammatory Bowel Disease Independent of Classic Metabolic Risk Factors. Clinical Gastroenterology and Hepatology 2023; 21(2): 406 doi: 10.1016/j.cgh.2022.01.039
|
| 6 |
Mia J. Coleman, Luis M. Espino, Hernan Lebensohn, Marija V. Zimkute, Negar Yaghooti, Christina L. Ling, Jessica M. Gross, Natalia Listwan, Sandra Cano, Vanessa Garcia, Debbie M. Lovato, Susan L. Tigert, Drew R. Jones, Rama R. Gullapalli, Neal E. Rakov, Euriko G. Torrazza Perez, Eliseo F. Castillo. Individuals with Metabolic Syndrome Show Altered Fecal Lipidomic Profiles with No Signs of Intestinal Inflammation or Increased Intestinal Permeability. Metabolites 2022; 12(5): 431 doi: 10.3390/metabo12050431
|
| 7 |
|
| 8 |
Sara Jarmakiewicz-Czaja, Jolanta Gruszecka, Rafał Filip. What Do NAFLD, Liver Fibrosis, and Inflammatory Bowel Disease Have in Common? Review of the Current Literature. Metabolites 2023; 13(3): 378 doi: 10.3390/metabo13030378
|
| 9 |
Waleed Alghamdi, Mahmoud Mosli, Saleh A. Alqahtani. Gut microbiota in MAFLD: therapeutic and diagnostic implications. Therapeutic Advances in Endocrinology and Metabolism 2024; 15 doi: 10.1177/20420188241242937
|
| 10 |
Lanlan Chen, Zhongqi Fan, Xiaodong Sun, Wei Qiu, Yuguo Chen, Jianpeng Zhou, Guoyue Lv. Mendelian Randomization Rules Out Causation Between Inflammatory Bowel Disease and Non-Alcoholic Fatty Liver Disease. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.891410
|
| 11 |
Samuel J. Martínez-Domínguez, Sandra García-Mateo, Carla J. Gargallo-Puyuelo, Beatriz Gallego Llera, Engy Refaie, Pilar Callau, Carolina Mendi, Pedro M. Baptista, María Hernández Ainsa, María Teresa Arroyo-Villarino, Julia López de la Cruz, Javier Martínez-García, Erika Alfambra, Miguel Ángel Simón Marco, Javier Ampuero, Fernando Gomollón. Crohn´s disease is an independent risk factor for liver fibrosis in patients with inflammatory bowel disease and non-alcoholic fatty liver disease. European Journal of Internal Medicine 2024; 120: 99 doi: 10.1016/j.ejim.2023.10.019
|
| 12 |
Vlad Alexandru Ionescu, Gina Gheorghe, Valentin Nicolae Varlas, Ana Maria Alexandra Stanescu, Camelia Cristina Diaconu. Hepatobiliary Impairments in Patients with Inflammatory Bowel Diseases: The Current Approach. Gastroenterology Insights 2022; 14(1): 13 doi: 10.3390/gastroent14010002
|
| 13 |
Peter Hoffmann, Victoria Jung, Rouven Behnisch, Annika Gauss. Prevalence and risk factors of nonalcoholic fatty liver disease in patients with inflammatory bowel diseases: A cross-sectional and longitudinal analysis. World Journal of Gastroenterology 2020; 26(46): 7367-7381 doi: 10.3748/wjg.v26.i46.7367
|
| 14 |
E. van Lingen, M. E. Tushuizen, M. E. J. Steenhuis, T. van Deynen, J. Martens, D. Diaz-Infante Morales, A. E. van der Meulen-de Jong, I. Molendijk, S. van der Marel, P. W. J. Maljaars. Disease activity in inflammatory bowel disease patients is associated with increased liver fat content and liver fibrosis during follow-up. International Journal of Colorectal Disease 2022; 37(2): 349 doi: 10.1007/s00384-021-04065-8
|
| 15 |
Meng-Yu Wang, Zi-Xuan Wang, Lei-Jie Huang, Rui-Xu Yang, Zi-Yuan Zou, Wen-Song Ge, Tian-Yi Ren, Jian-Gao Fan. Premorbid Steatohepatitis Increases the Seriousness of Dextran Sulfate Sodium-induced Ulcerative Colitis in Mice. Journal of Clinical and Translational Hepatology 2022; 10(5): 847 doi: 10.14218/JCTH.2021.00315
|
| 16 |
Alireza Beheshti Maal, Mohammad Amin Shahrbaf, Bahareh Sadri, Nikoo Hossein-Khannazer, Mohammad Ali Mansournia, Massoud Vosough. Prevalence of Hepatobiliary Manifestations in Inflammatory Bowel Disease: A GRADE Assessed Systematic Review and Meta-Analysis of more than 1.7 Million Patients. Journal of Crohn's and Colitis 2024; 18(3): 360 doi: 10.1093/ecco-jcc/jjad157
|
| 17 |
Anca Trifan, Remus Stafie, Adrian Rotaru, Ermina Stratina, Sebastian Zenovia, Robert Nastasa, Laura Huiban, Tudor Cuciureanu, Cristina Muzica, Stefan Chiriac, Irina Girleanu, Ana-Maria Singeap, Catalin Sfarti, Camelia Cojocariu, Oana Petrea, Carol Stanciu. Screening for Liver Steatosis and Fibrosis in Patients with Inflammatory Bowel Disease Using Vibration Controlled Transient Elastography with Controlled Attenuation Parameter. Journal of Clinical Medicine 2022; 11(19): 5959 doi: 10.3390/jcm11195959
|
| 18 |
Pilar Navarro, Lucía Gutiérrez-Ramírez, Antonio Tejera-Muñoz, Ángel Arias, Alfredo J. Lucendo. Systematic Review and Meta-Analysis: Prevalence of Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Patients with Inflammatory Bowel Disease. Nutrients 2023; 15(21): 4507 doi: 10.3390/nu15214507
|
| 19 |
Zahra Namkhah, Fatemeh Naeini, Alireza Ostadrahimi, Helda Tutunchi, Mohammad Javad Hosseinzadeh‐Attar. The association of the adipokine zinc‐alpha2‐glycoprotein with non‐alcoholic fatty liver disease and related risk factors: A comprehensive systematic review. International Journal of Clinical Practice 2021; 75(7) doi: 10.1111/ijcp.13985
|
| 20 |
Ludovico Abenavoli, Rocco Spagnuolo, Giuseppe Guido Maria Scarlata, Emidio Scarpellini, Luigi Boccuto, Francesco Luzza. Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study. Medicina 2023; 59(11): 1935 doi: 10.3390/medicina59111935
|
| 21 |
Mohammad Zamani, Shaghayegh Alizadeh‐Tabari, Siddharth Singh, Rohit Loomba. Meta‐analysis: prevalence of, and risk factors for, non‐alcoholic fatty liver disease in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2022; 55(8): 894 doi: 10.1111/apt.16879
|
| 22 |
Extraintestinal manifestations of inflammatory bowel disease, nitroxidative stress and dysbiosis: What is the link between them?. BIOCELL 2021; 45(3): 461 doi: 10.32604/biocell.2021.014332
|
| 23 |
Somtochukwu Onwuzo, Antoine Boustany, Mustafa Saleh, Riya Gupta, Chidera Onwuzo, Jessy Mascarenhas Monteiro, Favour Lawrence, Chukwuemeka Obuekwe, Zoya Morani, Imad Asaad. Increased Risk of Non-Alcoholic Steatohepatitis in Patients With Inflammatory Bowel Disease: A Population-Based Study. Cureus 2023; doi: 10.7759/cureus.35854
|
| 24 |
Rebecca Little, Binita M. Kamath, Amanda Ricciuto. Pediatric Inflammatory Bowel Disease. 2023; : 129 doi: 10.1007/978-3-031-14744-9_11
|
| 25 |
Giulia Gibiino, Alessandro Sartini, Stefano Gitto, Cecilia Binda, Monica Sbrancia, Chiara Coluccio, Vittorio Sambri, Carlo Fabbri. The Other Side of Malnutrition in Inflammatory Bowel Disease (IBD): Non-Alcoholic Fatty Liver Disease. Nutrients 2021; 13(8): 2772 doi: 10.3390/nu13082772
|
| 26 |
Charalampia Amerikanou, Efstathia Papada, Aristea Gioxari, Ilias Smyrnioudis, Stamatia-Angeliki Kleftaki, Evdokia Valsamidou, Victoria Bruns, Rajarshi Banerjee, Maria Giovanna Trivella, Natasa Milic, Milica Medić-Stojanoska, Amalia Gastaldelli, Aimo Kannt, George V. Dedoussis, Andriana C. Kaliora. Mastiha has efficacy in immune-mediated inflammatory diseases through a microRNA-155 Th17 dependent action. Pharmacological Research 2021; 171: 105753 doi: 10.1016/j.phrs.2021.105753
|
| 27 |
Sara Massironi, Lorena Pirola, Giacomo Mulinacci, Antonio Ciaccio, Chiara Viganò, Andrea Palermo, Alessandra Zilli, Pietro Invernizzi, Silvio Danese. Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and Tricks. Inflammatory Bowel Diseases 2023; 29(9): 1477 doi: 10.1093/ibd/izac189
|
| 28 |
Girak Kim, Zuojia Chen, Jian Li, Jialie Luo, Felipe Castro-Martinez, Jan Wisniewski, Kairong Cui, Yan Wang, Jialei Sun, Xiaobai Ren, Susan E. Crawford, S. Patricia Becerra, Jimin Zhu, Taotao Liu, Sui Wang, Keji Zhao, Chuan Wu. Gut-liver axis calibrates intestinal stem cell fitness. Cell 2024; 187(4): 914 doi: 10.1016/j.cell.2024.01.001
|
| 29 |
Rossella Maresca, Irene Mignini, Simone Varca, Valentin Calvez, Fabrizio Termite, Giorgio Esposto, Lucrezia Laterza, Franco Scaldaferri, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco. Inflammatory Bowel Diseases and Non-Alcoholic Fatty Liver Disease: Piecing a Complex Puzzle Together. International Journal of Molecular Sciences 2024; 25(6): 3278 doi: 10.3390/ijms25063278
|
| 30 |
Apostolis Papaefthymiou, Spyros Potamianos, Antonis Goulas, Michael Doulberis, Jannis Kountouras, Stergios A Polyzos. Inflammatory Bowel Disease-associated Fatty Liver Disease: the Potential Effect of Biologic Agents. Journal of Crohn's and Colitis 2022; 16(5): 852 doi: 10.1093/ecco-jcc/jjab212
|
| 31 |
Yejoo Jeon, Berkeley N Limketkai. Implications of Dietary Impact on Hepatic Steatosis and IBD. Inflammatory Bowel Diseases 2021; 27(1): 10 doi: 10.1093/ibd/izaa098
|
| 32 |
Jeonghyeon Kwon, Chungho Lee, Sungbaek Heo, Bobae Kim, Chang-Kee Hyun. DSS-induced colitis is associated with adipose tissue dysfunction and disrupted hepatic lipid metabolism leading to hepatosteatosis and dyslipidemia in mice. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-84761-1
|
| 33 |
Peter B. Soeters, Peter W. de Leeuw. Reciprocal Translation Between Pathophysiology and Practice in Health and Disease. 2021; : 93 doi: 10.1016/B978-0-12-820205-0.00002-5
|
| 34 |
Yejoo Jeon, Berkeley N. Limketkai. Arrested Development: Slow Progression of Fibrosis in Patients with NAFLD and IBD. Digestive Diseases and Sciences 2021; 66(9): 2853 doi: 10.1007/s10620-020-06672-x
|
| 35 |
Fabio Chicco, Salvatore Magrì, Arianna Cingolani, Danilo Paduano, Mario Pesenti, Federica Zara, Francesca Tumbarello, Emanuela Urru, Alessandro Melis, Laura Casula, Massimo Claudio Fantini, Paolo Usai. Multidimensional Impact of Mediterranean Diet on IBD Patients. Inflammatory Bowel Diseases 2021; 27(1): 1 doi: 10.1093/ibd/izaa097
|
| 36 |
Lixia Li, Xinting Lan, Xi Peng, Shuai Shi, Yanlin Zhao, Wentao Liu, Qihui Luo, Lanlan Jia, Bin Feng, Zhengli Chen, Yuanfeng Zou, Chao Huang. Polysaccharide from Salviae miltiorrhizae Radix et Rhizoma Attenuates the Progress of Obesity-Induced Non-Alcoholic Fatty Liver Disease through Modulating Intestinal Microbiota-Related Gut–Liver Axis. International Journal of Molecular Sciences 2022; 23(18): 10620 doi: 10.3390/ijms231810620
|
| 37 |
Mercedes Perez-Carreras, Begoña Casis-Herce, Raquel Rivera, Inmaculada Fernandez, Pilar Martinez-Montiel, Victoria Villena. Non-alcoholic fatty liver disease in patients with intestinal, pulmonary or skin diseases: Inflammatory cross-talk that needs a multidisciplinary approach. World Journal of Gastroenterology 2021; 27(41): 7113-7124 doi: 10.3748/wjg.v27.i41.7113
|
| 38 |
Bo Shen, Junjun Wang, Yuecheng Guo, Tianyi Gu, Zhenyang Shen, Cui Zhou, Binghang Li, Xianjun Xu, Fei Li, Qidi Zhang, Xiaobo Cai, Hui Dong, Lungen Lu. Dextran Sulfate Sodium Salt-Induced Colitis Aggravates Gut Microbiota Dysbiosis and Liver Injury in Mice With Non-alcoholic Steatohepatitis. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.756299
|
| 39 |
Claudia Veltkamp, Shuai Lan, Eleni Korompoki, Karl-Heinz Weiss, Hartmut Schmidt, Helmut K. Seitz. Hepatic Steatosis and Fibrosis in Chronic Inflammatory Bowel Disease. Journal of Clinical Medicine 2022; 11(9): 2623 doi: 10.3390/jcm11092623
|
| 40 |
Manuela Cassotta, Danila Cianciosi, Rachele De Giuseppe, Maria Dolores Navarro-Hortal, Yasmany Armas Diaz, Tamara Yuliett Forbes-Hernández, Kilian Tutusaus Pifarre, Alina Eugenia Pascual Barrera, Giuseppe Grosso, Jianbo Xiao, Maurizio Battino, Francesca Giampieri. Possible role of nutrition in the prevention of inflammatory bowel disease–related colorectal cancer: A focus on human studies. Nutrition 2023; 110: 111980 doi: 10.1016/j.nut.2023.111980
|
| 41 |
Shun-Wen Hsiao, Ting-Chun Chen, Pei-Yuan Su, Chen-Ta Yang, Siou-Ping Huang, Yang-Yuan Chen, Hsu-Heng Yen. Metabolic Dysfunction-Associated Fatty Liver Disease in Taiwanese Patients with Inflammatory Bowel Disease: A Study in Patients with Clinical Remission. Diagnostics 2023; 13(20): 3268 doi: 10.3390/diagnostics13203268
|
| 42 |
Lorenz M. W. Holzner, Andrew J. Murray. Hypoxia-Inducible Factors as Key Players in the Pathogenesis of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.753268
|
| 43 |
Zhaofeng Shen, Mengyuan Zhang, Yijing Liu, Changchang Ge, Yi Lu, Hong Shen, Lei Zhu. Prevalence of metabolic syndrome in patients with inflammatory bowel disease: a systematic review and meta-analysis. BMJ Open 2024; 14(3): e074659 doi: 10.1136/bmjopen-2023-074659
|